Skip to main content
Equibles

Daniel G. Welch

Board Member

Prothena Corp Public Ltd Co (PRTA)

Board Member

Ultragenyx Pharmaceutical Inc. (RARE)

Equibles does not estimate personal net worth.

Get an email with a short summary when Prothena Corp Public Ltd Co publishes a filing, an earnings call transcript or a press release.

Get PRTA alerts

About Daniel G. Welch

Daniel G. Welch is recorded as Board Member at Prothena Corp Public Ltd Co (PRTA) and Board Member at Ultragenyx Pharmaceutical Inc. (RARE). The newest filing on record that lists Daniel G. Welch as Board Member at Prothena Corp Public Ltd Co (PRTA) is dated October 7, 2025. The newest filing on record that lists Daniel G. Welch as Board Member at Ultragenyx Pharmaceutical Inc. (RARE) is dated April 29, 2020. Daniel G. Welch was last confirmed as Board Member at Nuvation Bio Inc. (NUVB) in a filing dated July 30, 2024. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed May 18, 2026 that Daniel G. Welch was appointed Class I Director, effective May 14, 2026. Prothena Corp Public Ltd Co reported in an 8-K filed February 21, 2024 that Daniel G. Welch was appointed director, effective February 21, 2024. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 13, 2023 that Daniel G. Welch was appointed Class I Director, effective June 7, 2023. Prothena Corp Public Ltd Co is classified in the Biotechnology industry within the Healthcare sector. Ultragenyx Pharmaceutical Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prothena Corp Public Ltd Co includes Gene Kinney (CEO and Board Member), Lars G. Ekman (Chairman and Board Member), Brandon S. Smith (COO and Board Member) and 7 others.

“At the Annual Meeting, the Company's stockholders elected the Class I director nominees below to the Company's Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected.”
Ultragenyx Pharmaceutical Inc. Form 8-K, filed May 18, 2026 · Read the filing
“On February 21, 2024, the Board of Directors (the "Board") of Prothena Corporation plc (the "Company") increased the size of the Board and appointed Daniel G. Welch to serve as a director of the Company, effective immediately.”
Prothena Corp Public Ltd Co Form 8-K, filed February 21, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Prothena Corp Public Ltd Co

Leadership on record at Ultragenyx Pharmaceutical Inc.

Recent activity